
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits
David H. Mulama, Lorraine Z. Mutsvunguma, Jennifer Totonchy, et al.
Vaccine (2019) Vol. 37, Iss. 30, pp. 4184-4194
Open Access | Times Cited: 27
David H. Mulama, Lorraine Z. Mutsvunguma, Jennifer Totonchy, et al.
Vaccine (2019) Vol. 37, Iss. 30, pp. 4184-4194
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
Anna Lucia Tornesello, Maria Tagliamonte, Franco M. Buonaguro, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 227-227
Open Access | Times Cited: 67
Anna Lucia Tornesello, Maria Tagliamonte, Franco M. Buonaguro, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 227-227
Open Access | Times Cited: 67
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 43
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 43
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12963-12963
Open Access | Times Cited: 21
Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12963-12963
Open Access | Times Cited: 21
CHO cells for virus-like particle and subunit vaccine manufacturing
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2530-2542
Open Access | Times Cited: 6
Zalma V. Sanchez-Martinez, Sergio P. Alpuche-Lazcano, Matthew Stuible, et al.
Vaccine (2024) Vol. 42, Iss. 10, pp. 2530-2542
Open Access | Times Cited: 6
Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) – review
Nicoleta Iftode, Mihaela Rădulescu, Ștefan Sorin Aramă, et al.
Romanian Journal of Internal Medicine (2020) Vol. 58, Iss. 4, pp. 199-208
Open Access | Times Cited: 38
Nicoleta Iftode, Mihaela Rădulescu, Ștefan Sorin Aramă, et al.
Romanian Journal of Internal Medicine (2020) Vol. 58, Iss. 4, pp. 199-208
Open Access | Times Cited: 38
Glycoproteins gM and gN are indispensable factors for rhesus macaque rhadinovirus replication and spread but can be reconstituted by KSHV chimeras
Gavin Golas, Byung Park, Scott W. Wong
Journal of Virology (2025)
Open Access
Gavin Golas, Byung Park, Scott W. Wong
Journal of Virology (2025)
Open Access
Microorganisms-derived antigens for preventive anti-cancer vaccines
Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101192-101192
Closed Access | Times Cited: 9
Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101192-101192
Closed Access | Times Cited: 9
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
Gabriela M. Escalante, Joslyn Foley, Lorraine Z. Mutsvunguma, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 169-169
Open Access | Times Cited: 27
Gabriela M. Escalante, Joslyn Foley, Lorraine Z. Mutsvunguma, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 169-169
Open Access | Times Cited: 27
Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus
Michelle Böni, Lisa Rieble, Christian Münz
Viruses (2022) Vol. 14, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 15
Michelle Böni, Lisa Rieble, Christian Münz
Viruses (2022) Vol. 14, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 15
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes
Lorraine Z. Mutsvunguma, Esther Rodríguez, Gabriela M. Escalante, et al.
Virology (2019) Vol. 536, pp. 1-15
Open Access | Times Cited: 23
Lorraine Z. Mutsvunguma, Esther Rodríguez, Gabriela M. Escalante, et al.
Virology (2019) Vol. 536, pp. 1-15
Open Access | Times Cited: 23
Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review
Rekha Thiruvengadam, Jin Hee Kim
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115035-115035
Open Access | Times Cited: 7
Rekha Thiruvengadam, Jin Hee Kim
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115035-115035
Open Access | Times Cited: 7
The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals
Yasaman Mortazavi, Salum J. Lidenge, Tara Tran, et al.
Viruses (2020) Vol. 12, Iss. 3, pp. 256-256
Open Access | Times Cited: 18
Yasaman Mortazavi, Salum J. Lidenge, Tara Tran, et al.
Viruses (2020) Vol. 12, Iss. 3, pp. 256-256
Open Access | Times Cited: 18
Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization
Alex K. Lam, Romin Roshan, Wendell Miley, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 5
Alex K. Lam, Romin Roshan, Wendell Miley, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 5
Nanotechnology Frontiers in γ-Herpesviruses Treatments
Marisa Granato
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11407-11407
Open Access | Times Cited: 7
Marisa Granato
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11407-11407
Open Access | Times Cited: 7
Advances in Tumor Antigen‐Based Anticancer Immunotherapy: Recent Progress, Prevailing Challenges, and Future Perspective
Wei Shi, Shuang Chen, Fanglian Chi, et al.
Advanced Therapeutics (2022) Vol. 6, Iss. 2
Closed Access | Times Cited: 3
Wei Shi, Shuang Chen, Fanglian Chi, et al.
Advanced Therapeutics (2022) Vol. 6, Iss. 2
Closed Access | Times Cited: 3
Hypoxic reactivation of Kaposi’s Sarcoma associated Herpesvirus
Rajnish Kumar Singh, Atharva S. Torne, Erle S. Robertson
Cell Insight (2024) Vol. 3, Iss. 6, pp. 100200-100200
Open Access
Rajnish Kumar Singh, Atharva S. Torne, Erle S. Robertson
Cell Insight (2024) Vol. 3, Iss. 6, pp. 100200-100200
Open Access
Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the in vivo immunogenicity and efficacy of KSHV vaccine candidates
Wan-Shan Yang, Do-Kyun Kim, Soowon Kang, et al.
mBio (2024)
Open Access
Wan-Shan Yang, Do-Kyun Kim, Soowon Kang, et al.
mBio (2024)
Open Access
Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
Nelli S. Khudainazarova, Dmitriy L. Granovskiy, О. А. Кондакова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11979-11979
Open Access
Nelli S. Khudainazarova, Dmitriy L. Granovskiy, О. А. Кондакова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11979-11979
Open Access
Bladder Adenocarcinoma in a Constellation of Multiple Site Malignancies: An Unusual Case and Systematic Review
Daniel Porav-Hodade, Raul Gherasim, Andrada Loghin, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2510-2510
Open Access
Daniel Porav-Hodade, Raul Gherasim, Andrada Loghin, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2510-2510
Open Access
Increased human herpesvirus-8 neutralizing response during remission from Kaposi’s sarcoma
Hannah C. Byren, Angela Holzer, Alexander Müller, et al.
Journal of General Virology (2024) Vol. 105, Iss. 11
Closed Access
Hannah C. Byren, Angela Holzer, Alexander Müller, et al.
Journal of General Virology (2024) Vol. 105, Iss. 11
Closed Access
Human Herpesviruses: Kaposi’s Sarcoma and Other Malignancies
Ronit Sarid, Daniela Dünn-Kittenplon, Maria Luisa Calabrò
Springer eBooks (2023), pp. 1-72
Closed Access | Times Cited: 1
Ronit Sarid, Daniela Dünn-Kittenplon, Maria Luisa Calabrò
Springer eBooks (2023), pp. 1-72
Closed Access | Times Cited: 1
Advances in the Study of Kaposi’s Sarcoma in Human
Mohammad Salim
International Journal of Current Research and Review (2021) Vol. 13, Iss. 08, pp. 171-177
Open Access | Times Cited: 1
Mohammad Salim
International Journal of Current Research and Review (2021) Vol. 13, Iss. 08, pp. 171-177
Open Access | Times Cited: 1
A retrospective study of Kaposi’s sarcoma in Hotan region of Xinjiang, China
Hong Yang, Feng He, Aibibai Jielili, et al.
Medicine (2023) Vol. 102, Iss. 41, pp. e35552-e35552
Open Access
Hong Yang, Feng He, Aibibai Jielili, et al.
Medicine (2023) Vol. 102, Iss. 41, pp. e35552-e35552
Open Access
Identification of the Kaposi's Sarcoma-associated Herpesvirus (KSHV) Surface Glycoprotein Targets of Human KSHV-specific Neutralizing Antibody Responses
Yasaman Mortazavi
(2020)
Closed Access
Yasaman Mortazavi
(2020)
Closed Access
Isolated Kaposi sarcoma of the upper aerodigestive tract in immunocompetent individuals, an underrecognized entity with favorable prognosis
Abdelrahman Shabaan, Ahmad Mahmoud Alkashash, Tieying Hou, et al.
Ear Nose & Throat Journal (2022), pp. 014556132211281-014556132211281
Closed Access
Abdelrahman Shabaan, Ahmad Mahmoud Alkashash, Tieying Hou, et al.
Ear Nose & Throat Journal (2022), pp. 014556132211281-014556132211281
Closed Access